Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

BACKGROUND The AIDS Clinical Trials Group protocol 076 zidovudine prophylaxis regimen for HIV-1-infected pregnant women and their babies has been associated with a significant decrease in vertical HIV-1 transmission in non-breastfeeding women in developed countries. We compared the safety and efficacy of short-course nevirapine or zidovudine during labour and the first week of life. METHODS From November, 1997, to April, 1999, we enrolled 626 HIV-1-infected pregnant women at Mulago Hospital in Kampala, Uganda. We randomly assigned mothers nevirapine 200 mg orally at onset of labour and 2 mg/kg to babies within 72 h of birth, or zidovudine 600 mg orally to the mother at onset of labour and 300 mg every 3 h until delivery, and 4 mg/kg orally twice daily to babies for 7 days after birth. We tested babies for HIV-1 infection at birth, 6-8 weeks, and 14-16 weeks by HIV-1 RNA PCR. We assessed HIV-1 transmission and HIV-1-free survival with Kaplan-Meier analysis. FINDINGS Nearly all babies (98.8%) were breastfed, and 95.6% were still breastfeeding at age 14-16 weeks. The estimated risks of HIV-1 transmission in the zidovudine and nevirapine groups were: 10.4% and 8.2% at birth (p=0.354); 21.3% and 11.9% by age 6-8 weeks (p=0.0027); and 25.1% and 13.1% by age 14-16 weeks (p=0.0006). The efficacy of nevirapine compared with zidovudine was 47% (95% CI 20-64) up to age 14-16 weeks. The two regimens were well tolerated and adverse events were similar in the two groups. INTERPRETATION Nevirapine lowered the risk of HIV-1 transmission during the first 14-16 weeks of life by nearly 50% in a breastfeeding population. This simple and inexpensive regimen could decrease mother-to-child HIV-1 transmission in less-developed countries.

• Publication year

  1999

• Venue

  The Lancet

• Publication date

  1999-09-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(99)80008-7PMID 10485720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficiencies of Four Versions of the AMPLICOR HIV-1 MONITOR Test for Quantification of Different Subtypes of Human Immunodeficiency Virus Type 1

  1999cited by this paper
• HIV transmission through breastfeeding: a study in Malawi.

  1999cited by this paper
• Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.

  1999cited by this paper
• A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

  1999cited by this paper
• Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

  1999cited by this paper
• 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

  1999cited by this paper
• Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

  1999cited by this paper
• Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team.

  1998cited by this paper
• International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV.

  1998cited by this paper
• Mother‐to‐child transmission of HIV: implications of variation in maternal infectivity

  1998cited by this paper
• Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV.

  1998cited by this paper
• Surveillance for waterborne-disease outbreaks--United States, 1995-1996.

  1998cited by this paper
• Public Health Service Task Force Recommendations for the Use of Antiretrovial Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States

  1998cited by this paper
• Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

  1997cited by this paper
• Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire.

  1996cited by this paper
• Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo

  1996cited by this paper
• Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

  1996cited by this paper
• Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group.

  1995cited by this paper
• Reduction of maternal-infant transmission of human immunodeficiency virus 1 with zidovudine treatment

  1995cited by this paper
• Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. The Working Group on Mother-To-Child Transmission of HIV.

  1995cited by this paper
• Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

  1994cited by this paper
• Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories

  1992cited by this paper

• Effects of M-DEPTH model of depression care on maternal depression, functioning, and HIV care adherence, and infant developmental over eighteen months post-partum: results from a cluster randomized controlled trial

  2025cites this paper
• Two Decades and Counting Since the Abuja Summit: Where Do We Stand in the Fight Against HIV/AIDS-Related Maternal Mortality?

  2025cites this paper
• Current standards for HIV vertical transmission prevention.

  2025cites this paper
• ART to prevent vertical transmission in Latin America: where are we in the “Treat‐All” era?

  2025cites this paper
• Standard of prevention for infectious diseases' prevention clinical trials during pandemics: learning lessons for global policies from biomedical HIV prevention clinical trials and a case study of COVID-19

  2025cites this paper
• Maternal-Child Human Immunodeficiency Virus Clinical Trials Networks across the Ages.

  2024cites this paper
• Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential

  2024cites this paper
• Missed Opportunities: A Narrative Review on Why Nonoccupational Postexposure Prophylaxis for HIV Is Underutilized

  2024cites this paper
• Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review

  2024cites this paper
• HIV Knowledge and Sexual Behaviors in Perinatally Infected Ugandan Youth: A Cross-Sectional Survey

  2024cites this paper
• Trends and predictors of unmet need for family planning among women living with HIV in Zambia: implications for elimination of vertical transmission of HIV

  2024cites this paper
• The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission

  2023cites this paper
• Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far

  2023influential citation
• Can newborn infants with positive HIV soon after birth be diagnosed with intrauterine infection?

  2023cites this paper
• Adverse events of antiretroviral prophylaxis regimen for elimination and prevention of mother-to-child transmission among HIV-exposed infants

  2023influential citation
• Breastfeeding Among Women Living With HIV in the Era of Lifelong ART: An Observational Multicountry Study in Eastern and Southern Africa

  2023cites this paper
• Review of Medical Approaches for the Prevention of Perinatal Transmission of HIV Infection

  2022cites this paper
• Determinants of HIV Testing during Pregnancy among Pregnant Sudanese Women: A Cross-Sectional Study

  2022cites this paper
• Central Nervous System and Neurodevelopmental Outcomes of HIV+ and HIV exposed children: A Mini Review of Recent Findings and Lessons Learned from the Field.

  2022cites this paper
• THE VALUE OF PARACLINICAL EXAMINATIONS IN ORAL PATHOLOGY IN CHILDREN AND YOUNG PEOPLE WITH SOME BLOOD DISCRASIONS

  2022cites this paper
• Prevention of Mother-to-Child Human Immunodeficiency Virus Transmission in Resource-Limited Countries.

  2022cites this paper
• Twenty years of Prevention of Mother to Child HIV Transmission: research to implementation at a national referral hospital in Uganda

  2022cites this paper
• Hunger and Adherence to Antiretroviral Therapy: Learning From HIV Positive Caregivers of Orphans and Vulnerable Children in Tanzania

  2022cites this paper
• Antiretroviral Therapy

  2022cites this paper
• Review of antiretroviral therapy coverage in 10 highest burden HIV countries in Africa: 2015–2020

  2022cites this paper
• Editorial: A century of health professions' education, training, academic research and service at Makerere University, Kampala, Uganda

  2022cites this paper
• Early diagnosis, vertical transmission of HIV and its associated factors among exposed infants after implementation of the Option B+ regime in Ethiopia: a systematic review and meta-analysis

  2022cites this paper
• Health Service delivery and training at Makerere University College of Health Sciences: The role of the academic health centers' network

  2022cites this paper
• Pediatric AIDS-Therapeutic Successes Built on a Foundation of Pediatric Clinical Pharmacology with Pharmacokinetic-Pharmacodynamic Modeling.

  2022cites this paper
• Sulfation of 12-hydroxy-nevirapine by human SULTs and the effects of genetic polymorphisms of SULT1A1 and SULT2A1.

  2022cites this paper
• Integrating HIV prevention and care into maternal and child health Integrating HIV prevention and care into maternal and child health care settings: Lessons learned from Horizons studies care settings: Lessons learned from Horizons studies

  2022cites this paper
• Factors associated with antiretroviral therapy use among pregnant women in rural and urban settings in Southern Province, Zambia: 2016–2019

  2022cites this paper
• Incidence and Predictors of Loss to Follow-Up Among Pregnant and Lactating Mothers Living with HIV and Enrolled in HIV Care Clinic in Ethiopia: A Systematic Review and Meta-Analysis

  2021cites this paper
• From Undetectable Equals Untransmittable (U=U) to Breastfeeding: Is the Jump Short?

  2021cites this paper
• "No" to placebo-controlled trials of Covid-19 vaccines.

  2021cites this paper
• Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications

  2021cites this paper
• A mathematical model of how non-adherence to HIV management guidelines for infected newborns contribute to the spread of HIV/AIDS

  2021cites this paper
• HIV in Neonates and Infants.

  2021cites this paper
• AIDS and COVID: A tale of two pandemics and the role of statisticians

  2021cites this paper
• A Pilot Study to Evaluate the Impact of the HIV Infant Tracking System (HITSystem 2.0) on Priority Prevention of Mother-to-Child Transmission (PMTCT) Outcomes

  2021cites this paper
• When to Initiate Antiretroviral Therapy, With Protocol for Rapid Initiation

  2020cites this paper
• HIV Transmission: Statistical Modelling

  2020cites this paper
• Trial designs for evaluating combination HIV prevention approaches

  2020cites this paper
• The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early child-

  2020cites this paper
• Providing Universal Access While Avoiding Antiretroviral Resistance: Ethical Tensions in HIV Treatment

  2020cites this paper
• Prevention of HIV Infection

  2020cites this paper
• Human Immunodeficiency Virus Infection

  2020cites this paper
• AIDS in children and dental management

  2020cites this paper
• Perinatal antiretroviral intensification to prevent intrapartum HIV transmission when antenatal antiretroviral therapy is initiated less than 8 weeks prior to delivery.

  2020cites this paper
• Prevention of Mother to Child Transmission of HIV

  2020cites this paper
• Mid-trimester cervical length not associated with HIV status among pregnant women in Botswana

  2020cites this paper
• Copper (triazole-5-yl)methanamine complexes onto MCM-41: the synthesis of pyridine-containing pseudopeptides through the 6-endo-dig cyclization of 1,5-enynes

  2020cites this paper
• LSHTM Research Online

  2020cites this paper
• Predictive Factors of HIV Testing Uptake among Pregnant Women in Nigeria- 2013 Demographic Health Survey

  2020cites this paper
• An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy

  2020cites this paper
• Viral infections of the central nervous system in Africa.

  2019cites this paper
• Option B+ prevention of mother-to-child transmission of HIV/AIDS service intervention outcomes in selected health facilities, Adama town, Ethiopia

  2019cites this paper
• Knowledge, Attitudes And Practices on Infant Feeding Options in the Context of Pmtct for Postnatal Mothers Attending Mbagathi District Hospital, in Nairobi County, Kenya

  2019cites this paper
• Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination

  2019cites this paper
• Adapting the HIV Infant Tracking System to Support Prevention of Mother-to-Child Transmission of HIV in Kenya: Protocol for an Intervention Development Pilot Study in Two Hospitals

  2019cites this paper
• The Incidence of Virological Success and Its Independent Predictors Following A Short Course of HAART among HAART Naïve HIV Positive Pregnant Women in Nnewi

  2019cites this paper
• The Immune System

  2019cites this paper
• The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions

  2019cites this paper
• Serum n-6 Fatty Acids are Positively Associated with Growth in 6-to-10-Year Old Ugandan Children Regardless of HIV Status—A Cross-Sectional Study

  2019cites this paper
• VIH-SIDA Y EMBARAZO: ACTUALIZACION Y REALIDAD EN CHILE *

  2019cites this paper
• Effectiveness of PEP in Preventing Occupational HIV Infection

  2019cites this paper
• Multidrug Regimen for Prevention of Mother-to-child Transmission in Human Immunodeficiency Virus-positive Mothers in India—From Prevention toward Elimination

  2019cites this paper
• Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.

  2019cites this paper
• Introduction of HIV Transmission

  2019cites this paper
• Nonoccupational Postexposure Prophylaxis and Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention in Adolescents and Young Adults.

  2019cites this paper
• Option B+ prevention of mother-to-child transmission of HIV/AIDS service intervention outcomes in selected health facilities, Adama town, Ethiopia

  2019cites this paper
• Meta Analysis of Genetic Variants of HIV Mother to Child Transmission

  2019cites this paper
• Incidence, prevalence and associated factors of mother-to-child transmission of HIV, among children exposed to maternal HIV, in Belgaum district, Karnataka, India

  2019cites this paper
• Designing & Conducting Trials to Reliably Evaluate HIV Prevention Interventions

  2019cites this paper
• Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study

  2019cites this paper
• An overview of advances in global maternal health: From broad to specific improvements

  2019cites this paper
• Focus on infection

  2019cites this paper
• Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.

  2019cites this paper
• Population uptake and effectiveness of test‐and‐treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross‐national analysis

  2019cites this paper
• HIV and Infant Feeding

  2018cites this paper
• A stage structured model for HIV/AIDS in the presence of vertical transmission: The case of Ghana

  2018cites this paper
• Prevention and Treatment of Pediatric HIV Infection

  2018cites this paper
• Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations

  2018cites this paper
• Feeding Practices and Nutritional Status of HIV-Positive Mothers and Exposed-Infants in Abeokuta , Ogun State , Nigeria

  2018cites this paper
• Mother to Child Transmission of HIV after Option B+ in Low Income Environment

  2018influential citation
• Future of nonnucleoside reverse transcriptase inhibitors

  2018cites this paper
• Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015

  2018cites this paper
• Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs

  2018cites this paper
• Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus

  2018cites this paper
• Synthèse de dérivés de la Névirapine substitués au carbone 13 pour l’étude de l’activation métabolique de cet antirétroviral dans des épidermes humains reconstruits

  2018cites this paper
• The Collaborative Role of North American Departments of Pediatrics in Global Child Health

  2018cites this paper
• Nevirapine‐polycaprolactone crystalline inclusion complex as a potential long‐acting injectable solid form

  2018cites this paper
• Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa

  2018cites this paper
• Political trust and the enforcement of constitutional social rights

  2018cites this paper
• 6 Effectiveness of the Regular Implementation of the Mother to Child Transmission Plus ( MTCT-Plus ) Program in Burkina Faso , West Africa

  2018cites this paper
• Viral, Protozoan, and Related Intracranial Infections

  2018cites this paper
• The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.

  2018cites this paper
• Acceptability and feasibility of the test

  2017cites this paper
• Tackling HIV and AIDS: contributions by non-human primate models

  2017cites this paper
• Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity

  2017cites this paper